InvestorsHub Logo
icon url

Larppis

11/27/22 12:41 AM

#539289 RE: ATLnsider #539288

There are actually two different sites to read about the SPORE projects. On the other one they specifically mention Merck and Pembrolizumab (Keytruda), on the other one they do not.

This one has the mention:
https://trp.cancer.gov/spores/abstracts/ucla_brain.htm

This one does not:
https://cancer.ucla.edu/research/ucla-brain-spore/research-projects
icon url

Doc logic

11/27/22 1:09 AM

#539292 RE: ATLnsider #539288

ATLnsider,

Always interesting to see what is not mentioned, like Poly ICLC. Seems the effort here is to focus the combo message on the major players even though more is known. Of course if survival at 10 years goes from over 50% to closer to 100% ie “tumor elimination” then there is at least a decent pretext for doing so. Best wishes.
icon url

biosectinvestor

11/27/22 8:02 PM

#539572 RE: ATLnsider #539288

Correct, in all documentation related to these trials it is always about the category of drug, not the company that might provide the drug or their sponsorship.